News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Sponsor & Foundation News

Teva Recalls Generic Parkinsonís Drug

Medtronic Buys Sapiens SBS

The Michael J. Fox Foundation for Parkinsonís Research Awards $2M Grant to Biotie for Parkinson's Dementia Clinical Study

The Michael J. Fox Foundation for Parkinson's Research Awards Second Grant to Cynapsus Therapeutics

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUDô

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson`s Disease and Movement Disorders

Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Verciseô DBS System For Patients With Parkinson's Disease

National Parkinson Foundation Study Finds U.S. Neurologist Care Saves 4,600 Lives of People with Parkinsonís Disease Each Year

FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinsonís Disease

Teva`s Parkinson Drug Now Marketed in Japan

CEO of The Parkinson Alliance Appointed to Brookingsí National Medical Device Postmarket Surveillance System Planning Board

The Parkinson Alliance Reports Findings Pertaining to Sleep in Parkinson`s

AbbVie Announces Availability of New Advanced Parkinson`s Treatment in Canada

Boston Scientific Corporation Enrolls the First Patient in a New Registry to Evaluate the Value of the Verciseô Deep Brain Stimulation (DBS) System

MRI Interventions' Clearpoint System Now Utilized at Emory University in Atlanta

Parkinson`s Disease Foundation Announces $20,000 in Grant Funding for Patient-Centered Research to Speed New Treatments

Parkinson`s Organizations Applaud Efforts to Bring More Drugs to Market

New survey available on "Autonomic Symptoms in Parkinson's Disease"

Study Evaluating Additional Indications for Tevaís Azilect

FDA Approves Chelsea Therapeuticsí Northera for Treatment of Neurogenic Orthostatic Hypotension

Berg And The Parkinson's Institute And Clinical Center Announce Key Clinical Study Focused On Game-changing Innovations In Parkinson's Disease Biomarker Discovery

National Parkinson Foundation Partners with SBR Health Provide Increased Access to Expert Parkinson's Disease Care

Crossing the Lines Between Parkinson's and Alzheimer's

LSVT LOUD and LSVT BIG Now Available in Clay County, Florida

Asleep During Brain Surgery: A Comfortable Alternative for Patients with Parkinson's Disease

Medtronic Recently Received FDA Approval of Updated Labeling for DBS for Parkinsonís Disease

The Parkinson Alliance Reports Findings on Falls and Fear of Falling in Parkinson's Disease With and Without Deep Brain Stimulation

US WorldMeds Launches Final Phase III Trial to Study Myobloc Injections to Treat Drooling

New Parkinson's Disease Genes Discovered by the Parkinson's Institute and Clinical Center and Population Diagnostics, Inc.

The Michael J. Fox Foundation Expands Fox Trial Finder to Help Accelerate Parkinson's Trials Worldwide

The Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinson's Disease Biomarker

Voice Program Boosts Speech in Parkinson's

UCB Highlights Educational Support Programs for People Living with Parkinson's Disease at the 2013 World Parkinson Congress

The National Parkinson Foundation Launches Spanish and Low Health Literacy Versions of Free Hospitalization Kit

The Parkinson Alliance to Attend Victory Summit Symposium

LSVTís At-Home Voice Training Software Helps Parkinson's Patients Improve Speech

Michael J. Fox Foundation CEO Stresses Need for Collaboration in Scientific Research

Listen to The Parkinson Alliance Discussion Regarding Resilience and Parkinsonís on Voice Aerobics BlogTalkRadio

New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy

back to top